PERSPECTA

News from every angle

Back to headlines

FDA Advisory Panel to Review Regulation of Wellness Peptides

An advisory panel to the Food and Drug Administration is scheduled to meet this week to provide recommendations on whether specialized pharmacies should be permitted to produce certain popular wellness peptides.

22 Jul, 09:00 — 22 Jul, 09:00
PostShare